Furthermore, the lncRNA tumor suppressor candidate 8 (TUSC8) can inhibit the evolution of papillary thyroid carcinoma via the miR-190b myosin regulatory light chain interacting protein (MYLIP) axis, which in turn can inhibit breast cancer growth and metastasis (38). The gene discussed is MYLIP; the disease is thyroid gland papillary carcinoma.